OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID
NCT02523118
Status
Recruiting

Conditions

  • Eosinophilic Colitis
  • Eosinophilic Esophagitis
  • Eosinophilic Gastritis
  • Eosinophilic Gastroenteritis
  • Eosinophilic Gastrointestinal Disorders (EGIDs)

Eligibility Criteria

Sex
ALL
Age
3 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.

Key Dates

Start date
Jul 17, 2015
Status verified
Aug 2025
Primary completion
Dec 1, 2050
Completion
Jan 1, 2051

Study Design

Enrollment
1,350 participants (estimated)

Primary Outcome Measure

Mucosal eosinophilia (eos/hpf) [ Time Frame: Duration of funding, at least 10 years ]

Central Contacts

Locations (19)

FacilityCityStateZIPSite coordinators
Mayo Clinic HospitalPhoenixArizona85054
Renee Nunez
480-301-4992
Benjamin Wright, M.D. (PRINCIPAL_INVESTIGATOR)
Arkansas Children's Research InstituteRogersArkansas72758
Allison Bruton
501-364-1060
Robert Pesek, MD (PRINCIPAL_INVESTIGATOR)
Rady Children's HospitalSan DiegoCalifornia92123
Kira Chaiboonma
(858)-966-1700
Seema Aceves, M.D., PhD (PRINCIPAL_INVESTIGATOR)
University of Colorado DenverAuroraColorado80045
Keanna Capener
303-724-8974
Paul Menard-Katcher, MD (PRINCIPAL_INVESTIGATOR)
Children's Hospital ColoradoDenverColorado80218
Rachel Andrews
(720) 777-1994
Glenn Furuta, M.D. (PRINCIPAL_INVESTIGATOR)
Ann and Robert H. Lurie Children's Hospital of ChicagoChicagoIllinois60611
Mary Riordan
312-227-4558
Joshua Wechsler, M.D. (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60208
Tenesha Thomas
Ikuo Hirano, M.D. (PRINCIPAL_INVESTIGATOR)
Riley Children's HospitalIndianapolisIndiana46202-
National Institutes of Health (NIH)BethesdaMaryland20892
Perla Adames-Castillo
Paneez Khoury, MD (PRINCIPAL_INVESTIGATOR)
Tufts UniversityBostonMassachusetts02111-
Mayo ClinicRochesterMinnesota55902-
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Jaimie Gowatsky
212-241-4908
Mirna Chehade, MD (PRINCIPAL_INVESTIGATOR)
University of North Carolina, Chapel HillChapel HillNorth Carolina27599
Lucas Plott
919-966-8559
Evan Dellon, M.D., MPH (PRINCIPAL_INVESTIGATOR)
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229
Bliss Magella
513-636-7832
Marc E. Rothenberg, MD, PhD (PRINCIPAL_INVESTIGATOR)
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Ignacio De La Torre
215-590-6187
Jonathan Spergel, MD, PhD (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Erin Lee
215-662-2493
Maureen DeMarshall
215-349-8546
Kristle Lynch, M.D. (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical CenterNashvilleTennessee37232
Regina Tyree
(615) 343-6845
Girish Hiremath, MD, MPH (PRINCIPAL_INVESTIGATOR)
Baylor College of Medicine & Texas Children's HospitalHoustonTexas77030
Amanda Vega
832-824-0939
Daisy Vita (Tran)
(832)-824-3640
Carla Davis, MD (PRINCIPAL_INVESTIGATOR)
University of UtahSalt Lake CityUtah84112
Sophia Schuman
801-585-0894
Kathryn Peterson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

Related Studies